Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Rolls-Royce Shares Lose Power After Revenue Warning

Fri, 17th Oct 2014 10:35

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Rolls-Royce Holdings updated its guidance for the full year and next year, while providing medium-term guidance, as it said it now expects underlying revenue this year to be lower and said its outlook for 2015 has become more challenging. The aerospace group said it expects underlying revenue for the full year to be 3.5% to 4% lower, compared to previous guidance of flat revenue against the comparable year. This includes adverse foreign exchange translation for the group estimated at GBP500 million, the same as it has previously announced.
----------
A subsidiary of WPP has taken legal action to prevent the UK government from moving a GBP400 million contract to a competitor and has obtained a court order to block public access to information on the case, the Financial Times reported on Thursday. WPP's GroupM filed a claim in the High Court in London last month to challenge a decision by the government to award a contract, worth GBP100 million per year over four years, to Carat, an agency owned by rival Dentsu Aegis Network Ltd.
----------
Petrofac said it has received record awards for its engineering, construction, operations and management (ECOM) activities as it remains on track to hit profit targets for all of 2014. The company reported an order intake totalling USD9.4 billion for the year to date for its engineering, construction, operations and management sector. Its group backlog, unfinished work or customer orders that have been received but are either incomplete or in the process of completion, increased to USD21.2 billion at September 30, compared to USD20.3 billion at June 30, giving good revenue visibility for the remainder of 2014, it said in a statement.
----------
Old Mutual said its wealth division is acquiring Quilter Cheviot, which is known for serving the affluent and high-net-worth segments of the UK private client market, for up to GBP585 million, in a move to bolster its own discretionary investment management capabilities. Old Mutual expects the deal to meet the group's return on equity target of 12% to 15% and generate annual group synergies of GBP15 million by 2017. According to Old Mutual, Quilter Cheviot had GBP16.2 billion of funds under management at the end of September, as well as 38,000 clients.
----------
Travis Perkins said the encouraging momentum in its business reported in its half-year results has continued, with total sales and like-for-like sales growing in the third quarter and trading consistent with that seen in the first half, though shares in the group dropped as the sales growth rate slowed against the first half. The FTSE 100-listed building merchant said total sales increased 6.9% in the quarter to September 30 year-on-year, with like-for-like sales increasing 5.7%. In the first half, sales increased 10.2%. The reported slowdown caused shares in the company to decline 0.6% to 1,628.00 pence in morning trade, making it one of the worst performers in the index.
----------
GlaxoSmithKline has said its Ebola vaccine will "come too late" for the current epidemic, the BBC reported. Ripley Ballou, the head of the FTSE 100 pharmaceuticals group's Ebola vaccine research team, said full data on the safety and efficacy of its Ebola drug would not be ready until late 2015. Glaxo is one of a number of companies attempting to fast-track a vaccine for the disease as the death tolls mounts in West Africa and as cases start to appear in Europe and the US.
----------
RSA Insurance Group said it has agreed to sell Italian business RSA Italy to ITAS Mutua, and expects to book a GBP28 million gain on the sale. The insurer said it has a deal to sell the entire business of the Italian branches of Royal & Sun Alliance Insurance PLC and the Sun Insurance Office Ltd, which together make up RSA Italy. In a statement, RSA said it expects to recognise a GBP28 million gain on the sale and an increase in its tangible net assets of about GBP8 million. It also said the sale will boost its Insurance Groups Directive surplus, a measure of regulatory capital, by about GBP50 million.
----------
Provident Financial said it is well positioned to deliver good quality growth for the whole of its current financial year as its Vanquis Bank reported growth in customers and average receivables. In a statement, Provident Financial said Vanquis Bank generated "strong growth and margins" in the UK through the third quarter of 2014, with year-on-year customer growth of 17% and average receivables growth of approximately 32%.
----------
Colt Group appointed Hugo Eales as its chief financial officer, with effect from November 1. Eales is the former CFO for BT Global Services, an arm of BT Group PLC. His appointment comes after Mark Ferrari decided to return to Fidelity Investments following his secondment from the US investment manager. He will step down from the Colt board as an executive director on October 31 and leave the company on December 31.
----------
Jimmy Choo said it would price its upcoming initial public offering at 140 pence per share, the bottom of the indicative range for the deal. The luxury shoemaker said that, based on the 140 pence per share price, the total market capitalisation of the company when conditional dealings start will be GBP545.6 million. The pricing is at the low end of its indicative range. It had originally set an offer price range of 140-180p per share, before narrowing this to 140-160p this week.
----------
MARKETS
----------
Shares across Europe have rallied on some doveish comments by US and UK central bankers, while FTSE 100-listed Rolls Royce fell 11% after downgrading its short-term guidance for a second time this year.
----------
FTSE 100: up 0.9% at 6,253.59
FTSE 250: up 1.5% at 14,693.85
AIM ALL-SHARE: up 1.5% at 686.47
----------
The pound has pushed through the USD1.60 ceiling reversing recent loses in the absence of fresh economic data.
----------
GBP-USD: up at USD1.6087
EUR-USD: up at USD1.2813

GOLD: down at USD1,237.34 per ounce
OIL (Brent): up at USD87.00 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Bank of England Chief Economist Andrew Haldane said the UK interest rates could remain at a record low for a longer period than he expected three months ago. If there is a genuine uncertainty about the path of the economy, the optimal policy response may be to avoid the worst outcomes, he told local business leaders in Kenilworth, central England. He observed that the UK economy is as weak as at any time in the recent or distant past and it is firmly on the back foot. "The UK economy appears to be writhing in both agony and ecstasy," Haldane said.
----------
Eurozone construction output increased at a faster pace in August, data from Eurostat showed. Construction output advanced 1.5% month-on-month following a 0.3% rise in July. Building output was up 1.4% and civil engineering advanced 2.1%. Production in construction decreased 0.3% on a yearly basis, which was slower than the 0.5% drop in the prior month.
----------
British households perceive that the value of their home increased in October, a survey from Knight Frank and Markit Economic showed. The house price sentiment index rose to 60.7 in October from 60.6 in September. This was the nineteenth consecutive month that the reading has been above 50. Any figure above 50 indicates that prices are rising and the higher the figure, the steeper the increase.
----------
The EU's cap on bankers' bonuses is the "wrong policy", according to Bank of England Deputy Governor Andrew Bailey, whose criticisms come just a day after European authorities moved to stop banks from getting around the rules. Speaking at the City Banquet in London on Thursday evening, Bailey said that so-called role-based allowances are a response to a bad policy.
----------
European car sales grew at a faster pace in September, a monthly report released by the European Automobile Manufacturers Association showed. New passenger car sales increased 6.4% in September from last year following a 2.1% rise in August. Sales expanded for the thirteenth consecutive month.
The UK reported an increase of 5.6%.
----------
The Russian energy company Rosneft and a close associate of President Vladimir Putin have launched lawsuits against the EU for sanctions the bloc imposed over the conflict in Ukraine, the European Court of Justice said. The state-owned oil company and Arkady Rotenberg, a longtime friend and judo-sparring partner of Putin, filed challenges last week in the Luxembourg-based court to the economic sanctions. The EU imposed sanctions on members of Putin's inner circle in reaction to Russia's military intervention in Crimea and its alleged involvement in eastern Ukraine.
----------
Russian President Vladimir Putin and his Ukrainian counterpart Petro Poroshenko were due to meet early Friday with European leaders in a renewed push to resolve the conflict in eastern Ukraine.
The meeting is to take place on the sidelines of the Asia-Europe Meeting (ASEM) summit in the northern Italian city of Milan. It will be Putin and Poroshenko's third meeting since fighting broke out in eastern Ukraine earlier this year.
----------
Hong Kong police cleared another protest site early Friday after nearly three weeks of demonstrations for open elections in the semi-autonomous Chinese territory. Hundreds of officers removed barricades erected in the Mong Kok commercial and residential district, dispersing protesters within an hour and without significant resistance, local news reports said.
----------
The World Health Organization (WHO) is reviewing Ebola preparedness in 15 African countries, in order to prevent the disease from spreading across the continent, a senior WHO official said Thursday in Geneva. The UN health agency is focusing especially on countries bordering the three Ebola-affected countries of Guinea, Liberia and Sierra Leone, WHO's Isabelle Nuttall said. The number of Ebola cases in the three hardest-hit countries will surpass 9,000 this week, with the number expected to double every four weeks, Nuttall said. The number of deaths will climb above 4,500 this week, she added.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.